NTRK1 and non-small cell lung carcinoma: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that is aberrantly expressed in several human cancers, including an aggressive subtype of T-cell lymphoma known as ALK-expressing anaplastic large cell lymphoma (ALK+ ALCL), NSCLC and neuroblastoma [54,55].